Regulatory approval differences explain why Biafine is not sold over-the-counter in the United States.
the verdict
REFUTED
the evidence says no
refutedsupported
the weight of evidence
0 sources for · 1 against
Official FDA records demonstrate that Biafine is regulated in the United States as a medical device (specifically a wound and burn dressing) rather than an over-the-counter or prescription drug, refuting the claim that drug regulatory approval differences explain its availability status.
510(k) Premarket Notification
Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
510(k) Premarket Notification
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
New Search
Back To Search Results
Device Classification Name
Dressing, Wound And Burn, Hydrogel W/Drug And/Or Biologic
510(k) Number
K964240
Device Name
BIAFINE WOUND DRESSING EMULSION
Applicant
Medix Pharmaceuticals Americas, Inc.
1050 Connecticut Ave., NW
Washington,
DC
20036
Applicant Contact
WAYNE H MATELSKI
Correspondent
Medix Pharmaceuticals Americas, Inc.
1050 Connecticut Ave., NW
Washington,
DC
20036
Correspondent Contact
WAYNE H MATELSKI
Classification Product Code
MGQ
Date Received 10/24/1996
Decision Date 01/22/1997
Decision
Substantially Equivalent
(SESE)
510k Review Panel
General & Plastic Surgery
Statement
Statement
Type
Traditional
Reviewed by Third Party
No
Combination Product
No
Predetermined Change Control Plan Authorized
No
-
-
This website has been translated to Spanish from English, and is updated often. It is possible that some links will connect you to content only
available in English or some of the words on the page will appear in English until translation has been completed (usually within 24 hours). We
appreciate your patience with the translation process. In the case of any discrepancy in meaning, the English version is considered official. Thank
you for visiting esp.fda.gov/tabaco.
-->
Links on this page:
Page Last Updated: 08/03/2026
Note: If you need help accessing information in different file formats, see
Instructions for Downloading Viewers and